The stock of Venn Life Sciences Holdings PLC (LON:VENN) is a huge mover today! The stock increased 4.00% or GBX 0.9 on November 3, hitting GBX 23.4. About 220,457 shares traded hands or 94.88% up from the average. Venn Life Sciences Holdings PLC (LON:VENN) has declined 10.58% since April 6, 2016 and is downtrending. It has underperformed by 11.79% the S&P500.
The move comes after 6 months positive chart setup for the GBX 13.97 million company. It was reported on Nov, 3 by Barchart.com. We have GBX 52.18 PT which if reached, will make LON:VENN worth GBX 17.18M more.
Venn Life Sciences Holdings plc is a clinical research organization , which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The company has a market cap of 13.97 million GBP. The Firm has the innovation segment, which is focused on developing and commercializing skin technologies. It has a 16.26 P/E ratio. It provides drug development services through its subsidiary, Kinesis Pharma B.V.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.